New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
January 19, 2024 - Teva launched an AB-rated generic version of Corcept Therapeutics’ Korlym (mifepristone) 300 mg tablets.
Download PDF
Return to publications
